uniQure Announces 2019 Financial Results and Highlights Recent Company Progress
02 mars 2020 16h05 HE
|
uniQure Inc.
~ Patient Dosing Nearly Completed in Phase III HOPE-B Trial of Etranacogene Dezaparvovecin Hemophilia B ~ ~ First Patient Procedure in Phase I/II Clinical Trial of AMT-130 in Huntington’s Disease...
ATN Reports Fourth Quarter and Full Year 2019 Results
19 févr. 2020 17h01 HE
|
ATN International, Inc.
Continued growth in domestic and international telecom drives improved underlying operating resultsTelecom businesses well positioned to continue to deliver strong financial performance in 2020 ...